Dr. Bai Wenjun
白文俊
Professor; Chief Physician; Department of Urology, Andrology Division
Where they practice, who they consult.
- Peking University People's Hospital (北京大学人民医院), Beijing
- 30+ years in andrology
- Mandarin, English
What they personally lead.
Training and recognition
Member of the Chinese Medical Association Andrology Branch; PKU People's Hospital andrology division has published Chinese expert opinion on Peyronie's disease management including collagenase therapy and Nesbit/grafting surgery; the chronic prostatitis clinic uses standardized NIH-CPSI scoring and offers multimodal therapy
What to expect
Collagenase clostridium histolyticum (Xiaflex) for Peyronie's disease is not currently approved in mainland China as of early 2026; surgical correction (Nesbit, plication, grafting) remains the primary treatment for stable Peyronie's deformity. Confirm current treatment options before traveling. <!-- TODO: needs second source -->
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Bai Wenjun's background to other specialists in Beijing. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.